{"path":"W2023T1/W2023T1 Files/Screen Shot 2023-11-01 at 10.38.32 PM.png","text":"I ®e:\" P ot | 1L U anee of B e i 8w O = — Ik . Conclusions Drug-placebo differences in antidepressant efficacy increase as a function of baseline severity, but are relatively small even for severely depressed patients. The relationship between initial severity and antidepressant efficacy is attributable to decreased responsiveness to placebo among very severely depressed patients, rather than to increased responsiveness to medication. . - a2","libVersion":"0.3.2","langs":"eng"}